Overview
The Immunity Bundle combines Thymalin and MOTS-c to enable laboratory investigation into immune system regulation across both thymic and mitochondrial signaling domains. In research settings, this pairing allows examination of how immune regulatory pathways interact with mitochondrial-derived metabolic signaling within controlled experimental systems.
This bundle is supplied strictly for laboratory and investigational research purposes.
Compound Breakdown
Each peptide in the Immunity Bundle contributes a distinct immune-related signaling role:
Thymalin (10mg) — studied for its involvement in thymus-associated immune regulation and cellular differentiation pathways
MOTS-c (10mg) — investigated as a mitochondrial-derived peptide associated with metabolic regulation and mitochondrial–nuclear signaling communication
Together, these peptides allow researchers to explore immune regulatory frameworks that span thymic signaling and intracellular metabolic coordination.
Research Context
Research investigations involving the Immunity Bundle commonly explore:
Immune system regulation models
Thymic signaling and immune development pathways
Mitochondrial involvement in immune cell metabolism
Integrated immune–metabolic signaling frameworks
These investigations remain limited to controlled laboratory environments and do not imply clinical or therapeutic outcomes.
Related Categories
Researchers evaluating this bundle often review the individual components — Thymalin Peptide and MOTS-c Peptide — as well as adjacent formulations such as the Flow Bundle and metabolic-focused bundles.
